Pathway Financial Advisors’s Merck MRK Stock Holding History
Bought
Maintained
Sold
Other funds holding MRK
LMFP
AAMU
CRM
SP
ORIO
CNB
Pathway Financial Advisors's MRK Position: Q2 2026 in Review
Pathway Financial Advisors sold out of Merck (MRK) in Q2 2026, closing a stake of 2,137 shares — an estimated $258K sold.
Pathway Financial Advisors first reported a position in MRK in Q4 2017 and held it in 14 quarters. The position peaked at $358K in Q4 2025. 711 funds tracked by Wall St. Rank hold MRK as of Q2 2026.
- Pathway Financial Advisors reported no remaining Merck position as of Q2 2026 after selling out during the quarter.
- Pathway Financial Advisors sold 2,137 Merck shares in Q2 2026, an estimated $258K.
- Pathway Financial Advisors first reported a position in Merck in Q4 2017 and held it in 14 quarters.
- Pathway Financial Advisors's Merck position peaked at $358K in Q4 2025.
- 711 funds tracked by Wall St. Rank held Merck as of Q2 2026.
Based on Pathway Financial Advisors's 13F filing for Q2 2026, filed 6 Jul 2026.